Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 26 ... published in the Journal of Medicinal Food, "We investigated age-related changes in intestinal intraepithelial lymphocyte (IEL) subsets in mice by flow cytometric analysis and their ...
2009 NOV 24 ... network synchronizes through the exchange of action potentials that release vasoactive intestinal polypeptide, striking a compromise, free-running period close to 24 h long," scientists ...
2009 NOV 27 ... treatment. Interventional radiologists should be aware of the possibility of late-onset intestinal stricture," wrote H. Toyoda and colleagues. The researchers concluded: ...
2009 NOV 23 ... According to a study from Okinawa, Japan, "Hyperactivation and hyperpermeability of the intestinal epithelium is a hallmark of IBD. AM has been shown to reduce the severity of colitis in ...
2009 NOV 23 ... destroy human tissues, leading to invasive diseases such as ulcerative colitis or extra-intestinal abscesses. in order to identify the virulence factors of this parasite phenotypes and ...
2009 NOV 23 ... the United States, "IBD is characterized by a chronic, dysregulated immune response to intestinal bacteria. Past work has focused on the role of T cells and myeloid cells in mediating ...
2009 NOV 23 ... However, the total concentrations and relative amounts of SCFAs in the lumen vary with intestinal niche," scientists in Australia report. "Here we report that conditions ...
2009 NOV 23 ... "Of these, 43 were treated operatively and 12 nonoperatively. Primary diagnoses were intestinal problems in 29 patients (53%), including diverticulitis, ischemia, perforation, ...
2009 NOV 23 ... patent provides protection for rifaximin relating to treating bloating caused by small intestinal bacterial overgrowth associated with irritable bowel syndrome. The patent will be listed ...
2009 NOV 23 ... According to recent research from the United States, "Celiac disease is an intestinal disorder caused by an immunologic response to gluten, which results in diffuse damage to ...
2009 NOV 23 ... is a methionine derivative previously shown to modulate the immune system and protect intestinal membrane cells in humans and swine. Two 42 d trials were conducted to evaluate the ...
2009 NOV 27 ... yen0.2%; w/v) prolonged the release of IgY from the microcapsules during simulated intestinal fluid incubation (pH 6.8). However, above the 0.2% (w/v) level, no significant ...
2009 NOV 23 ... leukemia, autoimmune disease, and organ transplantation. But the effect of CD52 mAb on intestinal intraepithelial lymphocytes (IELs) was unknown," scientists writing in the journal ...
2009 NOV 23 ... like the production of colonic gas, and motility or sensitivity disturbances of the intestinal tract. The disorder is difficult to treat, and the wide spectrum of non-drug and drug ...
2009 NOV 23 ... sodium-dependent bile acid transporter (ASBT; SLC10A2) is the primary mechanism for intestinal bile acid reabsorption. In the colon, secondary bile acids increase the risk of ...
2009 NOV 26 ... pathogen E coli K4 and a certified probiotic, L paracasei F19. as controls. Adhesion to intestinal epithelial cells was evaluated using two cell lines, CaCo-2 and HT-29, through the plate ...
2009 NOV 23 ... "The purpose of this study was to investigate liver and intestinal ABCA1 expression and plasma HDL-C level in response to treadmill-running training in ...
2009 NOV 23 ... were tested for rotavirus with use of enzyme immunoassay. If available, resected intestinal tissue samples were tested for rotavirus with use of immunohistochemistical analysis and ...
2009 NOV 23 ... with FGP, 24 with normal gastric mucosa and 12 with atrophic gastritis with diffuse intestinal metaplasia (IM-gastritis), all Helicobacter pylori negative. The expression of all ...
2009 NOV 23 ... Denmark, "A key determinant for oral bioavailability of a drug candidate is the intestinal epithelial permeation of the drug candidate. This...
